BioCryst Pharmaceuticals shares owned by Handelsbanken Fonder AB
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Handelsbanken Fonder AB
from 13F filings
Historical chart of Handelsbanken Fonder AB investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Handelsbanken Fonder AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in BioCryst Pharmaceuticals by Handelsbanken Fonder AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $275k | 46k | 5.99 |
| 2023-09-30 | $251k | 36k | 7.07 |
| 2023-06-30 | $250k | 36k | 7.04 |
| 2023-03-31 | $296k | 36k | 8.34 |
| 2022-12-31 | $408k | 36k | 11.49 |
| 2022-09-30 | $341k | 27k | 12.58 |
| 2022-06-30 | $378k | 36k | 10.59 |
| 2022-03-31 | $580k | 36k | 16.25 |
| 2021-12-31 | $652k | 47k | 13.84 |
| 2021-09-30 | $944k | 66k | 14.37 |
| 2021-06-30 | $941k | 60k | 15.82 |